ACCESS clinically-linked biospecimens
Target RWE has collected over 115,000 biospecimens from consented participants across a broad range of therapeutic indications, including oncology, hepatology, gastroenterology, dermatology, and other autoimmune diseases. These samples are collected leveraging an IRB-approved protocol and linked to de-identified clinically validated data derived from patient medical records and patient research outcomes measures. The inventory includes whole blood, serum, plasma, saliva, tissue, and tape strips. Biospecimens are collected, handled, and stored according to validated standard operating procedures and robust quality requirements.
Target RWE partners can access these samples to conduct research analyses and real-time testing, such as biomarker characterizations, diagnostic assay development and validation, sequencing, and genotyping. Analytical outputs generated from such research can also be integrated with additional historical, phenotypic, categorical and analytical data curated by Target RWE.